Common diabetes drug tested as potential brain shield for MS
NCT ID NCT06463743
Summary
This study is testing if metformin, a medication commonly used for diabetes, can help protect the brain from damage in older adults with multiple sclerosis (MS). Researchers will compare metformin to a placebo (inactive pill) in 30 participants aged 55-75 to see if it's safe and if it helps slow brain injury measured by MRI scans over 9 months. The goal is to see if this well-known drug could offer a new way to manage the long-term effects of MS.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UBMD Neurolgy
RECRUITINGBuffalo, New York, 14203, United States
Conditions
Explore the condition pages connected to this study.